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by Lester D. Grant*
Several compelling aruguments have been advanced in support of expanding the use of
"'behavioral teratology" evaluations as routine components of toxicologic screening procedures.
As a basis for development of effective behavioral teratology screening approaches, a conceptual
framework is presented which interrelates: (1) changes in relative functional brain capacity with
age, (2( possible times and durations of exposures to environmental insults, and (3) various types
of toxicity testing procedures carried out at appropriate time points in relation to different ex-
posure periods. Within that context, several research strategies for behavioral teratology studies
are concisely posed and evaluated. These include: I1) clinical hypothesis testing, where particular
effect s) of a given agent are evaluated based on hypotheses derived from clinical or epidemiolog-
ical observations; (2) comprehensive screening approaches, where multifaceted, long-term
longitudinal neurobehavioral evaluations are employed to assess whether any ofa large number of
possible deletarious effects are exerted by an agent and at what threshold exposure levels; (3)
alternative screening heuristics, by which adequate assessments of neurobehavioral toxicity of
various agents may be accomplished without completion ofmore exhaustive, but also more expen-
sive and time-consuming comprehensive screening protocols.
Introduction
Considerable interest has developed in recent
years among toxicologists and other biomedical
specialists in regard to the evaluation of
neurobehavioral effects of known or suspected
toxic agents. The growth of interest in
"behavioral toxicology" research has been
stimulated in part by extensive documentation.
accumulated over the past 10-20 years, of
numerous examples of deleterious neurological
and behavioral effects associated with exposure
of humans and animals to various environmental
agents and drugs, as reviewed in several relevant
symposium volumes (1-3). Research described in
the above volumes and other published reports
have also contributed to calls in Congress (4) for
the enactment of federal statutes requiring
behavioral assessments as components of future
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toxicity screening procedures. Importantaly for
the present discussion, among the recom-
mendations under consideration are ones con-
cerning the postnatal evaluation of toxic effects
on behavior following environmental insults early
in development, i.e., during prenatal or early
postnatal periods.
Several arguments have been advanced as
justification for expanding neurobehavioral
toxicity screening efforts in general and for
behavioral teratology screening in particular as
an area of special importance. It has been noted,
for example, that "Since behavior represents an
integrated response of the organism, an im-
pairment in the functioning of nearly any system
may be reflected as indicators that some, as yet
covert, toxic action has occurred" (5). That
significant behavioral changes may occur at ex-
posure levels for some agents insufficient to
produce histologically detectable damage to the
central nervous system or other organs is
suggested by studies such as those on hyper-
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present session (6). To the extent that behavioral
changes do occur sooner on a dose-response curve
for toxic effects than other signs of toxicity, e.g.,
anatomical abnormalities, then deviations from
normal behavior patterns may comprise an "early
warning system" (7) presaging more severe and
overtly obvious damage induced by an agent at
higher doses or after longer exposure periods.
Aside from serving as early warning signals, un-
desirable behavioral effects in and of themselves
may constitute a substantial cost associated with
exposure to a particular agent, particularly if
irreversible severe behavioral deficits are in-
duced by the agent. Both of these arguments are
compelling points supporting the need for ex-
panded behaviroal toxicology screening efforts.
As for more specifically including behavioral
teratology-studies as a regular component of
such screening procedures, it has been argued
(5,8,9), on the basis of strong evidence, that the
developing nervous system may be particularly
vulnerable to the damaging effects of many
agents. This is perhaps most dramatically
epitomized to date by the unfortunate conse-
quences of exposures to low levels of methylmer-
cury during pregnancy, as outlined in descrip-
tions ofthe insiduous nature of Minamata Disease
and its counterpart induced in experimental
animal models (9).
Given that convincing arguments can be made
for expanding behavioral toxicology research in
general and behavioral teratology efforts in par-
ticular, many problems remain concerning how to
accomplish this goal most effectively, especially if
such evaluations are to be routinely conducted as
part of standardized toxicity screening
procedures. As of yet, no single clear-cut answer
or definitive approach has yet emerged that can
be recommended without reservations. Most
alternatives are beset by their own special dif-
ficulties or disadvantage, as well as by frequent
common problems centering around immense
monetary, space, and personnel commitments,
plus lengthy time spans necessary to carry them
through to decisive outcomes. Nevertheless,
much pertinent information does exist in the
neurobiology, behavioral toxicology, psychophar-
macology, and experimental/developmental psy-
chology literature that can be called upon in an ef-
fort here to pose briefly and evaluate several
possible alternative research strategies for con-
ducting behavioral teratology assessments.
Definingthe Scopeofthe Problem
How one conceptualizes the overall dimensions
of a particular problem obviously often deter-
mines much about the alternatives that might be
contemplated for dealing with it. In this case, con-
structing even a very general conceptual
framework concerning the likely "biology" of
potential exposure problems and expected time
courses of associated pathological processes aids
greatly in definingthe full scope ofthe problem at
hand and provides hints as to possible approaches
needed to deal with it.
The key concept upon which the present
theoretical framework is based is what will be
termed here "functional brain capacity." It is by
no means a completely new concept, nor is the
present use of the concept in relation to
behavioral toxicology problems novel. Kety (10),
in 1956, as described by Weiss and Simon (11),
estimated the rate of normal decline with age of
the functional capacity of the brain based on
changes in various indices of brain function.
These included, for example, decreases in
cerebral blood flow, cerebral oxygen con-
sumption, and cortical neuron density as a func-
tion of age. Weiss and Simon (11) plotted the nor-
mal expected decline in functional capacity, as
defined by neuronal cell density and predicted by
Kety's calculations, in relation to chronological
age, using 25 years as a base of 100% capacity.
They then went on to extrapolate from Kety's
figures and to plot graphically estimated ac-
celerated rates of decline in functional capacity if
a hypothetical environmental insult at age 25 in-
duced even very small excess rates (of 0.1% to
1.0% excess/year) of cell loss. As the Weiss and
Simon (11) plots well illustrate, the anticipated
cummulative effect on functional capacity over
many years of even such small excess rates of cell
loss can be expected to be quite substantial. For
example, with just 0.5% excess cell loss per year
from age 25, the expected functional capacity at
chronological age 55 can be projected to be
reduced to a level roughly equivalent to that
which would have been seen at 70 years if a nor-
mal rate of decline in neuronal density had oc-
curred.
As indicated by Weiss and Simon (11), their
calculations were not meant to represent a
precise model of any specific known en-
vironmental exposure situation or its con-
sequences. Nevertheless, assessment of changes
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systems of it would appear to be the key
theoretical issue implicitly addressed by most
studies of neuro-behavioral toxicity. In view of
this, consideration here of possible effects on
functional brain capacity of hypothetical en-
vironmental insults of varying durations and oc-
curring at different stages of life will be used as a
basis for subsequent discussion of different
behavioral teratology research approaches.
For present purposes, the concept of functional
brain capacity should be explicitly broadened to
reflect not just such indices as cerebral blood flow
and neuronal cell density in the brain. Rather, it
is defined here as also reflecting the number or
density of functionally intact neurons in the en-
tire central nervous system (CNS) and its
peripheral extensions, the number or density of
functionally intact, nonaberrant synaptic con-
nections therein, and the intactness of various
associated neurochemical processes, e.g.,
neurotransmitter synthesis, release, and
degradation. All of these are factors determining
the maximum complexity of neurobehavioral
processes capable of being mediated by the ner-
vous system of an organism and the reserve
capacity available to it to sustain such processes
under challenging circumstances. A hypothetical
curve representing net relative levels of func-
tional brain capacity, determined by balancing off
the above factors at different periods of life for
most mammalian species, is incorporated in the
overall conceptual scheme illustrated in Figure 1.
RELATIVE FUNCTIONAL
BRAIN CAPACITY
In regard to the normal course of changes in
functional capacity thought to occur over time af-
ter conception, as represented by the curve at the
top of Figure 1, functional capacity is seen here as
steadily rising prenatally and neonatally. This
reflects the rapid proliferation of neural tissue
during early development and the establishment
of functional synaptic contacts as the brain
matures. In regard to the former process, i.e., cell
proliferation, data on actual periods of maximum
proliferation of neurons comprising different
regions in the brain ofthe rat and mouse are sum-
marized in this session's paper by Rodier (12) and
indicate that neural proliferation in some brain
areas continues for some time after birth. As the
proliferation process ends, however, functional
brain capacity probably begins to reach as asymp-
tote, likely sometime not long after puberty, and
is seen in the present scheme as leveling off for a
prolonged period during adulthood. This is based
on the likely offsetting of the effects of con-
tinuous normal cell deaths by gains in processing
efficiency, e.g., as would be expected to occur as
new synaptic connections are laid down and other
changes result from "learning" or experience.
Later in life, functional brain capacity is shown to
decline, starting at some point in old age or
"geriatric" life period. This decline in functional
capacity occurs when the accumulated effects of
cell losses and other harmful shifts in neural func-
tion begin to predominate and lead to the
manifestation of neurobehavioral deficits defined
as "senility" or "senescence."
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FIGURE 1. Schematic representation of conceptual framework upon which are based suggestions for longitudinal designs for be-
havioral teratology studies. Normal changes in relative levels of functional brain capacity, determining the maximum com-
plexity of neurobehavioral responses and the neural reserve of an organism, are plotted (top) in relation to periods and events
occurring during the life span of most mammalian species. Various types of experimental exposure periods are depicted in re-
lation to different points in life when they might be administered to reflect actual types of exposure problems. Toxicity testing
points (*), when different types of anatomical and behavioral evaluations are appropriately conducted, are noted in relation
to the exposure periods.
December 1976
LIFE PER ODS
AND EVENTS
TOX IC ITY
TES T N G
POI NTS
9,,.\k
10Vla.%
Z
87Now let us examine how and when toxic agents
might exert effects that alter this normal pattern
of initial growth, relative stability, and later
decline in funcational brain capactiy. Also let us
determine appropriate points for testing for such
toxic effects. As depicted at the bottom right of
Figure 1, during adulthood, mature brain func-
tioning could be affected at various times by ex-
posures of varying durations, ranging from brief
acute exposures to somewhat longer subacute or
much longer chronic exposures. One must suspect
that the geriatric period would be a particulary
vulnerable time for the induction of deleterious
effects by exposures of any duration, given the
likely additive nature of toxic effects with
degenerative senescence processes already un-
derway. In regard to testing for toxic effects on
behavior, various testing procedures appropriate
for adult subjects are available and could be em-
ployed at several possible points in relation to dif-
ferent exposure periods, as also indicated in
Figure 1. This might first start with establish-
ment of pre-exposure behavioral baselines or, in
other cases, such testing might not commence un-
til exposures begin or soon after their ter-
mination, provided that appropriate control
groups are employed. In addition, if no effects are
immediately found upon initial testing at the time
of exposure, it should be remembered that cer-
tain agents have already been shown to induce
progressive damage that would be detectable
only by later, delayed testing long after the
precipitating exposure had ceased. This suggests
that, if initial results are negative, then repeated
tests at intervals throughout the rest of the test
subjects' lives may be necessary to really be sure
that no hidden, long-delayed exposure effects are
missed. Again, the geriatric period is likely a
highly vulnerable time for such delayed effects to
be manifested. Thus, "old age" testing may be
especially crucial in seeking out delayed exposure
effects, with an ill-defined generalized premature
senscence possibly being one syndrome induced
by an otherwise apparently harmless agent. It
can also be argued that repeated testing at in-
tervals should be conducted even if deficits are
found with initial tests, in order to ascertain
whether or not the effects observed are per-
manent or if recovery of function occurs. In sum,
the logic just outlined constitutes a general
rationale, based on the functional brain capacity
concept discussed earlier, which could be applied
in planning behavioral toxicology evaluations of
adult subjects.
In regard to exposure periods and testing
points more specifically ofrelevance to behavioral
teratology studies, such exposure periods are
depicted mainly at the bottom left ofFigure 1 and
include pregestational, prenatal, and neonatal
ones, or combinations of all three or even con-
tinous whole-life chronic exposures. For ex-
posures occurring before birth, prenatal em-
bryotoxicity-teratology screening at various
points during gestation and postnatal develop-
mental testing would be appropriate. The latter
would be useful as well for evaluation ofeffects of
exposures started at birth or soon after and
should not only include assessment of changes oc-
curring very early neonatally, but also evaluation
somewhat later of events associated with the oc-
currence ofpuberty. Adult behavioral testing and
later geriatric period testing would also be
desirable, in order to test for delayed effects ap-
pearing during maturity or for the induction of
premature senescence by agents passing
evaluations carried out earlier in development.
Other comments in the preceding paragraph
regarding the need for repeated testing at in-
tervals throughout adulthood also apply here.
The logic behind the pattern of testing just
outlined demands that the same subjects be
reevaluated at many points in their lives, thus
requiring that longitudinal research designs be
employed, as alluded to in Figure 1.
To summarize what is implied by the preceding
discussion within the context of the conceptual
framework depicted in Figure 1, exposures to
toxic agents early in development are seen as
possibly exerting three general types of effects
on functional brain capacity: (1) slowing or retar-
dation of the normally marked increase in func-
tional capacity early in life, as the brain and the
rest of the nervous system undergo maturational
development (In essence, this type of effect
would constitute a shifting to the right of the
initial ascending portion of the curve represen-
ting functional capacity in Figure 1); (2) trun-
cation of the total normal growth of functional
capacity or lowering of the ultimate maximum
level attained at maturity, resulting in decreased
complexity of behavior mediated in adulthood or
decreased ability to cope under challenging cir-
cumstances when one aspect or another of neural
functioning is pushed to its limits (Note that this
second type of effect need not necessarily be an
invariant sequela to the occurrence of the first
type of exposure effect, i.e. the induction delayed
development); (3) advancement in time or exacer-
bation of the decline in functional capacity nor-
mally seen late in life or the induction of
premature senescence, signified by a shift to the
left of the last portion of the curve in Figure 1.
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degenerative processes or the addition of still
other types of deletarious effects as the residue
ofearly insults.)
The different general categories of evaluations
mentioned above, then, are seen as the means by
which these three types of effects of early toxic
exposures can be effectively demonstrated at ap-
propriate periods following early insults.
Prenatal teratology screening and postnatal
developmental testing, for example, assess the
occurrence of the first type of effect listed. Adult
behavioral testing employed later, with the
repetition of certain specific tests at intervals,
assesses whether the last two types of effects
have occurred and helps to evaluate recovery
from any deficits found earlier. With the scope of
the present problem now better defined and at
least some general steps needed to deal with it
noted, let us proceed to more specific con-
sideration of different behavioral teratology
research strategies that might be applied as
toxicity screening approaches.
Clinical HypothesisTesting Approaches
Some appreciation for the rather large dimen-
sions and compex nature of the task confronting
scientists attempting to screen for
neurobehavioral toxicity effects can be gained
from the discussion of the abstract conceptual
framework outlined above. The full enormity of
the problem, however, is not brought home com-
pletely until one tries to translate the im-
plications of such a theoretical scheme into
recommendations for practical action. Questions
of importance abound, such as: (1) What species
should be used as experimental subjects? (2)
What doses and exposure regimens should be
utilized for agents to be evaluated? (3) What
behaviors or other neural functions should be
assessed and in what order? (4) Which specific
tests for particular functions should be em-
ployed? (5) How does one interpret results from
the various tests? (6) What constitutes sufficient
evidence of toxicity to warrant the rejection or
banning of a particular agent? It is beyond the
scope of present purposes to attempt to deal with
all of these issues or any signle one in exhaustive
detail. Rather, selected aspects of some will be
discussed, with the reader being referred to
other articles for more detailed information or
views on various points.
The issue of what functions should be assessed
and in what sequence forms one major focal point
for the remaining discussion. In the past, one of
the main determinents of which functions were
chosen for evaluation was the presentation of
clinical or epidemiological evidence that par-
ticular functions in humans are affected by a
suspected toxin. To illustrate, what will be ter-
med here as a "clinical hypothesis testing" ap-
proach is essentially the unstated model that can
be discerned as having guided much of the ex-
perimental research over the past several years
on the neuro-behavioral effects of two heavy
metals, mercury (as methylmercury) and lead.
Clinical and epidemiological reports of
neurological deficits seen in humans and descrip-
tions of symptoms seen in nonlaboratory animals
suffering from Minamata disease stimulated ex-
perimental screening for particular types of
neurobehavioral deficits following methylmer-
cury poisoning, as described by Spyker (9,13).
Similarly, clinical reports (14,15) implicating low
level lead exposures as being a possible causitive
factor in the etiology of hyperactivity in children
have helped to generate numerous animal model
evaluations (16-18) aimed at assessing that
possibility experimentally.
Clinical hypothesis testing approaches of the
above type have certainly generated useful in-
formation confirming at least some clinically
derived suspicions about particular agents and
have helped to define threshold doses for induc-
tion of toxic effects. Such approaches, however,
suffer from the obvious disadvantage of demon-
strating deleterious effects after notable damage
to human populations has presumably already oc-
curred. In fact, that inadequacy accounts in part
for the substantial inpetus behind current efforts
to institute new screening approaches designed
to detect harmful effects of agents before they
are released into the environment. Still, if we use
as our guide the wide variety of symptoms re-
ported in humans as being associated with expo-
sure to different toxic agents (19), then it very
quickly becomes clear that any "pre-release"
behavioral screening approach should ideally be
very broad or comprehensive, indeed, in regard
to the types of functions assessed. This is neces-
sitated by the factthat so many types offunctions
could be adversely affected by an agent, based on
past experience, and yet there is virtually no cer-
tain way to predict a priori which specific func-
tion(s) will be affected by a particular agent. In
essence, casting a wide net by means of a com-
prehensive approach would help to maximize the
chances of almost any kind of behavioral deficit
being picked up by the screening procedures.
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Some examples of fairly comprehensive
behavioral screening approaches have been
outlined in the literature (5,13). The former one
(5), in particular, is spelled out in considerable
detail and offers recommendations for following a
systematic sequence of discrete steps in
evaluating a new agent with unknown, but
possibly deleterious neurobehavioral effects. In
brief, it proposes initial testing of acute exposure
effects on adult subjects, using certain very gross
observations (an elementary screen) at first to
detect overtly obvious signs of toxicity. After
repetition of testing with the "elementary
screen" following an interval of time in order to
assess delayed effects or recovery from earlier ef-
fects, it is recommended that prenatal exposures
be carried out and assessment of the offspring by
a maturational-development screen be un-
dertaken. Depending upon the outcome of that
screen and for other subsequent ones, in-
creasingly more sophisticated behavioral
assessments are suggested in order to define
even more specific behavioral deficits. After each
major evaluation step, decision points are in-
dicated where interpretation ofaccumulated data
leads either to (1) rejection of the agent being
tested and cessation of testing or (2) further
testing until chronic exposures are finally
evaluated, if warranted by anticipated exposure
patterns for the agent. A wide variety of
behavioral evaluations are suggested as possibly
being undertaken as part of the elementary
screen, the maturational-develpment screen, or
the successively more sensitive later behavioral
assessments.
Another comprehensive screening approach,
incorporating many features of the sequential
analysis described above but designed very
specifically for use in behavioral teratology
studies, is depicted in Table 1. This complete
screening approach assumes prenatal exposure to
the agent under evaluation. Also, given that the
main advantage of behavioral teratology tests
presumbly lies in detecting toxic effects at ex-
posure levels below those producing gross overt
toxicity or histologically demonstrable signs of
anatomical damage in adult subjects, it is recom-
mended that the present approach be reserved
only for use in evaluation of relatively low level
exposures to a given agent. That is, only ap-
parently subtoxic exposure levels, as defined first
by other screening procedures with exposure
of adult subjects, should be employed here, star-
ting with at least the highest apparent subtoxic
exposure level. As for evaluations, top priority
should initially be assigned to carrying out a so-
called "perinatal teratology screen." This screen
would involve analyses ofembryotoxicity, as well
as gross anatomical inspections and/or histologi-
cal analyses, with special attention accorded the
central nervous system, organs of special sense,
endocrine organs, and reproductive organs. The
term "perinatal" is used here to emphasize that
not only should such analyses be carried out on
fetuses harvested prior to birth, but also perhaps
neonatally during suckling or even a bit later,
once proliferation of neural tissue should have
been completed. Still later, neuropathology eval-
uations might also be conducted. Anatomical
damage detected by any of the above assess-
ments would argue strongly for rejection of an
agent at the offending exposure levels. Lack of
effects at this point for given exposures, how-
ever, signals the need for further testing.
Further testing would next consist of con-
ducting a postnatal development screen on sub-
jects not sacrificed for teratology screening. The
postnatal development screen would evaluate the
types of variables listed in Table 1. Evaluations
designed to assess the progress of maturation
early in development might profitably include not
only behavioral tests, but also measures of
growth and physical development. This allows for
estimates of whether behavioral changes likely
indicative of altered neural function occur at ex-
posure levels below those producing general ef-
fects on growth or maturation of other organ
systems. Thus, ages at which certain physical
development landmarks, e.g., incisor eruption,
eye opening, descent of testes, and vaginal
opening appear, should be recorded. In addition,
behavioral assessments should focus early in
postnatal development on (1) the maturation of
certain reflexes, e.g., righting responses,
auditory startle responses, and visual placing
response, (2) the shift of immature patterns of
locomotion and movement to more adult patterns,
and (3) the maturation of other functions, eg.
thermoregulatory responses. (More detailed
descriptions of possible postnatal development
assessments and their interpretation have been
given by Rodier (20). Stunting of growth, or
major delays in physical development or the
maturation of particular functions here argue
strongly for rejection of an agent, but further
testing would still be desirable to ascertain
whether or not any recovery offunction might oc-
cur later in life after various exposures levels.
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screening approach.a
Perinatal Teratology Screen
Central nervous system
Organs ofspecial sense
Endocrine organs
Reproductive system organs
Other organ systems
Postnatal Development Screen
Growth
Physical landmarks
Specific sensory-motor integration reflexes
Fine motor skills
Locomotor patterns
Activity levels
Thermoregulation
Adult Behavioral Testing
Preliminary Screen
Body weight changes
Objective signs
Reflex changes
Elicited responses
Gross motor changes
Body temperature
Intermediate testing
Consummatory responses
Activity patterns
Motor performance
Sensory perception
Sex/maternal behavior
Emotionality/aggression
Advan Ed testing
Classical conditioning
Operant conditioning
(Appetitive/aversive)
Memory processes
Sensory capabilities
Fine motor skills
aAssuming a prenatal exposure period, evaluations would
proceed in the following sequence: (1) perinatal teratology
screening; (2) postnatal development screening; (3) adult
behavior testing, proceeding from the preliminary screen
through intermediate testing to advanced testing, ifnecessary.
Conversely, failure to find effects here or detec-
tion of apparently minor developmental delays
does not necessarily establish the safety of an
agent. Rather, further testing would be needed
later in adulthood or in old age to determine
possible delayed effects.
Adult behavioral testing might then proceed in
a sequence consisting of increasingly more
sophisticated and difficult assessment
procedures. The first, and grossest level of
assessment, would consist of continuous
monitoring for overt signs of toxicity. Elemen-
tary or preliminary screens often already used by
pharmaceutical houses, would be employed for
this purpose. Observations usually requiring lit-
tle more than standardized ratings and minimum
equipment are made on the types of variables
listed for this first screening level. Objective
signs include general physical appearance, e.g.,
scruffiness of coat, abnormal postures, excessive
salivation or diarrhea, ptosis of the eyelid, and so
on. Elicited responses include reactions to han-
dling, reactions to nose or tail pinch, etc. Reflex
changes included alterations in righting respon-
ses, corneal or visual placing responses, and
auditory startle, among others. Observations of
gross motor changes include abnormal circling,
obstinate progression, hyper-or hypoactivity
during brief observation, and lack of grasping
reflexes. Presumably, toxic effects so grossly
manifested as to be detected by these procedures
would be considered to be severe enough to
justify cessation oftesting and probable rejection
of the agent tested. Failure to observe reliable ef-
fects here, however, by no means comes close to
establishing the nontoxicity of the agent at ex-
posure levels studied; rather, still more
sophisticated levels of behavioral testing would
be recommended for use.
The next or "intermediate" level of adult
behavioral testing would involve attempts at
quantifying changes in spontaneous behavioral
responses, e.g., monitoring locomotor activity,
food and water consumption, and also relatively
gross measures of motor performance or sensory
perception. The third or "advanced" level of
assessment, however, involves analyses of
behavior in much more controlled circumstances
and would include tasks such as operant con-
ditioning paradigms aimed at assessing an
agent's impact on learning and memory functions
and/or to detect even very small shifts in sensory
capabilities or fine motor skills. Weiss (5) lists
specific types of tests that might be used at this
level of analysis. Some functions, e.g., sleep, that
require electrophysiological assessments have
not been included here, but their evaluation
would also obviously be desirable. Given that
delayed effects of insults early in development
may not be manifested until late in adult life, one
or more components ofthe present adult behavior
testing procedure may need to be repeated,
especially as subjects begin to enter old age, in
order to detect induction ofpremature senscence.
Comprehensive testing approaches of the kind
outlined above would allow for a broad and de-
tailed description of myriad neurobehavioral ef-
fects induced by a given agent at various points in
life. They would, however, be very costly and
time-consuming to conduct, with final results not
available possibly for several years, depending on
the animal species used and whether testing
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in the face of lack of effects seen with early
screens. In fact, if a longitudinal approach of the
above type were to be applied in its entirity as a
routine "pre-release" screening program, then
the choice of test subjects would perforce be
realistically limited to species, such as mice or
rats, with life spans of less than 3-4 years. Even
with such test subjects, however, the likelihood
exists that is could take at up to 5 years to com-
plete a thorough, comprehensive evaluation of
the neurobehavioral effects of a given agent,
especially if detailed data were sought regarding
the types of subtle behavioral deficits most likely
to occur after exposures to otherwise apparently
subtoxic low levels of the agent. Detection of sub-
tle behavioral changes often require use of the
most sophisticated advanced behavioral testing
techniques available and even then they might
not be detectable until well into old age. Thus, the
cost in elapsed time, not to mention the com-
mitment of laboratory space, trained personnel,
and expensive equipment, can be expected to be
quite considerable if an all-out effort is un-
dertaken to identify the lowest exposures at
which an agent exerts even very minute
neurobehavioral effects.
A legitimate question arises, in view of the
above factors, as to whether the gain expected
really justifies the immense costs associated with
carrying out comprehensive screening ap-
proaches of the kind under discussion. In part,
this may depend upon the anticipated benefits to
be derived from use ofthe agent evaluated, which
is a factor helping to determine just how far one
might choose to proceed through a sequence of in-
creasingly more difficult analyses of neurobehav-
ioral effects (see 5 for more information dealing
with this point). Inronically, even if the entire
testing sequence is completed, one cannot be com-
pletely certain that no important effect has been
missed, as suggested elsewhere (6,12). Nor is it
always easy to extrapolate with confidence from
animal findings as to what their significance
might be in regard to human neurobehavioral
functions or the exposure levels needed to induce
a given defict in humans (12,20).
The above points could be construed as arguing
for the complete abandonment of any attempt at
large-scale neurobehavioral toxicity screening,
given the resources demanded, the possibility of'
still missing important deficits, and difficulties at
times in interpreting results and their signi-
ficance for predicting human exposure effects.
Quite to the contrary, despite these difficulties,
comprehensive screening programs of the type
outlined above likely do presently represent the
single best appraoch available to maximize the
probability that subtle neurobehavioral toxicity
effects will be detected and defined with some
precision; still, it would obviously be desirable if
alternative screening heuristics could be devel-
oped that would provide savings in time and re-
sources needed and yet not badly sacrifice the
likelihood of detecting significant neurobehavior-
al deficits. Some possibilities for moving in this
direction are briefly outlined below.
Alternative Screening Heuristics
Many possibilities exist for the development of
effective screening approaches as alternatives to
comprehensive, broad spectrum screening pro-
grams. Most, however, require that we be willing
to accept substantially less detailed information
than we might ideally like to have on the neuro-
behavioral effects of a given agent before recom-
mending its acceptance or rejection for release
into the environment.
One alternative approach is to try to narrow
down judiciously the range of functions assayed
for a particular agent, i.e., to set priorities for
particular types of neurobehavioral tests to be
carried out. The priorities set may be agent-
specific, in order to maximize the chance that a
given agent's most likely neurobehavioral effects
will be picked up. For example, if an agent is
chemically closely similar to a class of other toxic
substances known to cause deficits in certain
neurobehavioral functions, but not others, then
screening efforts for the agent under study might
be best concentrated on those functions affected
by the analogous substances. Another basis on
which priorities for conduction ofparticular types
of screening tests might be set would not be
agent-specific; rather, it would consist of
relegating to lowest priorities assessments of
particular functions for which the available
testing method ologies are not well established or
the results of which are difficult to interpret or
extrapolate to humans. Conversely, highest pri-
orities could be assigned to functions for which
the evaluation methodology is well worked out
and produces results that have generally been
found to be easily extrapolated to humans. Con-
trast, for example, the current state of affairs in
regard to the assaying of aggressive behaviors,
described recently (21) as being fraught with dif-
ficulties in interpretation of results and in ex-
trapolation of the likely meaning of results in so
far as they might apply to humans, with the much
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assaying sensory functions, which also yield
results often fairly directly extrapolatable to
humans (22,23). In other words, perhaps it would
be best to set priorities so as toemphasize screen-
ing efforts that are capable at the time ofyielding
solid, interpretable data, which would well define
particular neurobehavioral deficits. if they were
present. On the other hand, if we are willing to
accept less well-defined or seemingly innocuous
changes as indicators of likely altered functional
brain capacity and, therefore, potential toxicity,
then several other screening heuristics may well
prove to be useful screening short-cuts.
The key features of three such alterative ap-
proaches now under investigation as to their
potential usefulness for facilitating screening of
neurobehavioral deficits after environmental in-
sults early in development are: (1) assessment of
developmental delays as predictors ofsubsequent
adult neurobehavioral deficits; (2) behavioral
assessments by use of apical test paradigms that
simultaneously monitor multiple functions; (3)
employment of provocative drug tests as probes
for altered functional brain capacity. Each shows
promise of possibly shortening considerably the
time and effort needed to demonstrate effects
which likely constitute danger signals indicating
that an agent has or will later exert a significant
damaging effect on neurobehavioral functioning.
Inregard tothe first alternative, substantial time
could be saved in future behavioral teratology
screening efforts, if it were possible to show con-
vincingly that early delays in physical or behav-
ioral development, no matter how small, tran-
sient, or seemingly insignificant in and of them-
selves, nevertheless are highly predictive of
more serious later adult neurobehavioral deficits
to come. Iffurther research can establish this as a
general rule, then finding a developmental delay
relatively early in a behavioral teratology testing
sequence may be sufficient to warrant cessation
of further testing and immediate rejection of any
agent having little or no potential use value. Tem-
porary withholding of other agents having great-
er potential benefits might also be warranted,
pending more thorough analyses of any neurobe-
havioral deficits that appear after early delays in
development.
The logic behind use of apical test paradigms,
was spelled out in part by Butcher (6). Brivefly,
the main idea is to concentrate on developing
behavioral test paradigms that tap or assay
multiple neurobehavioral functions such that a
single test situation might be used in lieu of
several other types of evaluations aimed at
assessing single functions in detail. Successful
performance in many complex operant condition-
ing paradigms, for example, typically depends on
multiple neurobehavioral processes being intact.
Thus, deficits in performance in such situations
may be due to alterations in sensory or motor
functions, motivation, or learning and memory
processes. To be certain which of these )rocesses
has been affected can require extensive addi-
tional testing to pin down the exact souirce of the
performance deficit. However, if we are willing
simply to accept any alteration in performance in
such apical test situations as being indicative of
altered functional brain capacity after environ-
mental insult without going on to elucidate the
exact nature of the deficit, then this may form a
basis for more rapid screening ofagents.
The last alternative, the use of provcative drug
tests as probes for altered functional brain
capacity, is based on an extensive psychophar-
macology literature demonstrating that various
types ofdamage to the CNS result in increased or
decreased sensitivity to various drugs. Testing
for paradoxical responses to amphetamine after
low level lead exposures (17,18) represents one
example of employment of this type of screening
heuristic. Such provocative drug probes could be
used at various points after environmental in-
sults early in development, as schematically il-
lustrated in Figure 1. More research is needed to
establish whether altered response to drugs,
especially early in postnatal development, are
reliable predictors of other more serious prenatal
insult induced neurobehavioral deficits seen later
in life. If so, then such provocative drug tests may
represent yet another way ofsubstantially reduc-
ing the time and effort needed in order to demon-
strate sufficient evidence of danger of neurobe-
havioral toxicity to reject an agent early in a
screening sequence.
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